BARDA’s Big Bird Flu Vax Contract With Moderna
Last month, Moderna, Inc. slashed its revenue forecast for this year by $1 billion, prompting its stock price to plunge by more than 20 percent to $33.44. In September 2024, Moderna estimated its revenue for 2025 would be $2.5 billion to $3.5 billion, but the company revised its forecast on Jan. 13, 2025 to $1.5 […]
Atrial Fibrillation Linked to Age, COVID-19 and Vaccination on the Rise
Previous research has indicated that approximately 3 million people in the United States have atrial fibrillation (AFib); however, a 2024 study conducted by researchers from the University of California, San Francisco and published in the Journal of the American College of Cardiology has found that AFib is actually three times more prevalent in the U.S. […]
FDA Requires RSV Vaccine Labels to Include Guillain-Barré Syndrome Risk
On Jan. 7, 2025, the U.S. Food and Drug Administration (FDA) mandated and approved changes to the safety labeling for the Prescribing Information of two Respiratory Syncytial Virus (RSV) vaccines: Abrysvo (manufactured by Pfizer)1 and Arexvy (manufactured by GlaxoSmithKline Biologicals).2 This label change update is being required to inform both the public and health care […]
Three German Scientists Call for Immediate Halt on All mRNA Biologicals, Including COVID Shots
German authors of a new peer-reviewed study called for an “immediate halt of all mRNA biologicals,” ” including COVID-19 shots, until questions about residual DNA that well exceeds regulatory limits can be answered. The study, published on Dec. 3, 2024 in the Public Health Policy Journal, underscores concerns about the mRNA technology that includes the […]
Doctors Cash In: The Hidden Profits Behind Pediatric Vaccinations
Healthcare providers for years have been leading the charge in recommending—and often pressuring—parents to vaccinate their children. During the COVID-19 pandemic, strong endorsements from pediatricians played a significant role1 in the acceptance of experimental COVID-19 shots for kids, while parents expressed dismay at receiving dismissal letters for delaying or refusing a barrage of shots. What these […]
CDC Narrows RSV Vaccine Guidelines Due to Safety Concerns
The U.S. Centers for Disease Control and Prevention (CDC) has recently narrowed its original recommendations for the respiratory syncytial virus (RSV) vaccine, citing concerns over the risk of a side effect that can lead to paralysis or death. The recommendations originally stated adults over the age of 60 should receive the vaccine, but updates in […]